Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“When disodium ethane-1-hydroxy-1,1-diphosphonate EHDP ) was administered (50 mg/kg b.wt) from 2 days before until 2 days after vitamin D3 treatment, cyst calcification was inhibited.”
“We conclude that the combined treatment with etidronate and alfacalcidol additively increases the mass of bone with normal quality, resulting in bone strengthening in ovx rats.”
“To examine whether either of the two known active vitamin D metabolites 1,25(OH)2D3 or 24,25(OH)2D3 could reverse the mineralization defect induced by 1‐hydroxyethylidene‐1,1‐bis phosphonate (EHDP), a model of EHDP‐induced rickets was used.”
“This dose of EHDP enhances the intestinal accumulation of a vitamin D3 metabolite with the chromatographic characteristics of 1,25-dihydroxycholecalciferol.”
Clinical science and molecular medicine • 1975 | View Paper
“Abstract The administration of disodium-ethane-1-hydroxy-1,1-diphosphonate (20 mg/kg body weight subcutaneously) to chicks given adequate amounts of vitamin D 3 causes a hypercalcemia, inhibits bone mineralization, and inhibits intestinal calcium transport.”
“In rachitic chicks the disodium-ethane-1-hydroxy-1,1-diphosphonate treatment markedly reduces the 25-hydroxyvitamin D 3 -1-hydroxylase activity of kidney, but does not increase the 25-hydroxyvitamin D 3 -24-hydroxylase.”
Archives of biochemistry and biophysics • 1974 | View Paper
“Medical cost of concurrent therapy alphacalcidol and etidronate ) for osteoporosis was compared with those of no treatment and single therapies (alphacalcidol or etidronate) .”